SmartestCrowd
Organizations
Orgs
No organizations
Projects
No projects
0
0
AI biotech Earendil announces huge $787M raise, is reportedly considering Hong Kong IPO - Endpoints News
+ 48 more
3/20/26 at 3:16pm
Organization
Endpoints.news
Author
Andrew Dunn
42 words
0
Comments
Earendil Labs raises $787M for AI drug platform, with 40+ programs and Sanofi partnership. CEO Jian Peng leads US-headquartered, China-rooted biotech considering Hong Kong IPO.
Pharmaceuticals & Biotech
Business & Industrial
Company News
Venture Capital
Stocks & Bonds
Financial Markets News
Drugs & Medications
Health News
You are the first to view
https://endpoints.news/china-rooted-ai-biotech-earendil-labs-raises-787m-ahead-of-possible-ipo/
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...